| D008066 |
Lipolysis |
The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues. |
Lipolyses |
|
| D003300 |
Copper |
A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. |
Copper-63,Copper 63 |
|
| D004305 |
Dose-Response Relationship, Drug |
The relationship between the dose of an administered drug and the response of the organism to the drug. |
Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response |
|
| D000242 |
Cyclic AMP |
An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. |
Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic |
|
| D000818 |
Animals |
Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. |
Animal,Metazoa,Animalia |
|
| D013329 |
Structure-Activity Relationship |
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. |
Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships |
|
| D015394 |
Molecular Structure |
The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. |
Structure, Molecular,Molecular Structures,Structures, Molecular |
|
| D051379 |
Mice |
The common name for the genus Mus. |
Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus |
|
| D054684 |
Cyclic Nucleotide Phosphodiesterases, Type 3 |
A cyclic nucleotide phosphodiesterase subfamily that is inhibited by the binding of CYCLIC GMP to an allosteric domain found on the enzyme and through phosphorylation by regulatory kinases such as PROTEIN KINASE A and PROTEIN KINASE B. The two members of this family are referred to as type 3A, and type 3B, and are each product of a distinct gene. In addition multiple enzyme variants of each subtype can be produced due to multiple alternative mRNA splicing. |
Cyclic Nucleotide Phosphodiesterase PDE3 Family,Cyclic Nucleotide Phosphodiesterases, Type 3A,Cyclic Nucleotide Phosphodiesterases, Type 3B,Phosphodiesterase 3A,Phosphodiesterase 3B,Phosphodiesterase III,cGMP-Inhibited Cyclic Nucleotide Phosphodiesterase,cGMP-Inhibited Phosphodiesterase,Phosphodiesterase, cGMP-Inhibited,cGMP Inhibited Cyclic Nucleotide Phosphodiesterase,cGMP Inhibited Phosphodiesterase |
|
| D058987 |
Phosphodiesterase 3 Inhibitors |
Compounds that specifically inhibit PHOSPHODIESTERASE 3. |
PDE3 Inhibitor,Phosphodiesterase 3 Inhibitor,Phosphodiesterase Type 3 Inhibitor,PDE-3 Inhibitors,PDE3 Inhibitors,Phosphodiesterase Type 3 Inhibitors,3 Inhibitor, Phosphodiesterase,Inhibitor, PDE3,Inhibitor, Phosphodiesterase 3,Inhibitors, PDE-3,Inhibitors, PDE3,Inhibitors, Phosphodiesterase 3,PDE 3 Inhibitors |
|